Announcement on voluntary disclosure of the qualification status of the company and its subsidiaries from April to June 2024.
Announcement of Shareholding Reduction by Shareholder
Simplified Equity Change Report
Notice of Equity Change: Shareholders holding more than 5% of the shares will reduce their shareholdings to 5%.
Guangzhou LBP Medicine Science & Technology Investor Relations Activity Record (June 20, 2024)
Announcement on Shareholders with More Than 5% Shareholding's Plan to Reduce Shareholding
Guangzhou LBP Medicine Science & Technology Investor Relations Activity Record Table (June 5, 2024)
Anbiping Investor Relations Activity Record List (May 27, 2024)
Announcement on plans for shareholders holding 5% or more of the shares to reduce their holdings
2023 Annual Equity Distribution Implementation Notice
Legal Opinion of Guangdong Cinda Law Firm on the 2023 Annual General Meeting of Shareholders of Guangzhou Anbiping Pharmaceutical Technology Co., Ltd.
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Anbiping Investor Relations Activity Record Form (May 7, 2024)
Notice on Voluntary Disclosure of Obtaining a Medical Device Registration Certificate
2023 Annual General Meeting of Shareholders Meeting Materials
Legal Opinion of Guangdong Cinda Law Firm on matters relating to the abolition of some restricted stocks in the 2022 Restricted Stock Incentive Plan of Guangzhou Anbiping Pharmaceutical Technology Co., Ltd.
2024 First Quarter Report
Summary Report of Minsheng Securities Co., Ltd. on the sponsorship work of Guangzhou Anbiping Pharmaceutical Technology Co., Ltd. for the initial public offering and listing
Announcement of Resolutions of the Third Meeting of the Fourth Board of Supervisors
Announcement on the annulled portion of 2022 restricted shares granted that have not yet been vested
No Data